Clinical trial

Assessing Symptomatic Clinical Episodes in Depression

NCT03595579

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-05-30

PhasePHASE2

Study timeline

Study start (actual)2018-05-30Date precision: day

Registry last updated2021-09-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

AXS-05DRUG

BupropionDRUG · verified · RxNorm: bupropion

Sponsors & collaborators

Axsome Therapeutics, Inc.lead sponsor

Mapped research locations

JacksonvilleFlorida, United States1 OrlandoFlorida, United States1 Beverly HillsCalifornia, United States1 BellevueWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03595579 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.